Clinical Trial

Derivation of Induced Pluripotent Stem Cells From an Existing Collection of Human Somatic Cells

Recruiting
View on ClinicalTrials.gov →
Summary
Induced pluripotent stem cells potentially may be useful in the future as an unlimited source of cells for transplantation. The major goal of the project is to develop human iPS cells from various types of cell cultures or lines from existing collections. The IPS cells will be developed for modeling diseases, for developing the technology that may eventually allow the use of IPS cells for transplantation therapy, and for basic research.
Protocol Amendment History 30 amendments
This ClinicalTrials.gov record has been amended 30 times since 2008-12-02; most recent amendment 2025-03-02.
Status change: Active, Not Recruiting → Recruiting 2025-03-02
Status change: Recruiting → Active, Not Recruiting 2024-02-29
Status change: Active, Not Recruiting → Recruiting 2016-09-06
Trial Details
NCT Number NCT00801333
Lead Sponsor Hadassah Medical Organization
Conditions Amyotrophic Lateral Sclerosis
Enrollment 25 participants
Start Date 2008-11
Primary Completion 2030-12 (estimated)
Study Completion 2030-12 (estimated)
Updated on ClinicalTrials.gov 2025-03-05